FURMONERTINIB
Clinical trials for FURMONERTINIB explained in plain language.
Never miss a new study
Get alerted when new FURMONERTINIB trials appear
Sign up with your email to follow new studies for FURMONERTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New dosing strategy aims to fight lung Cancer's spread to the brain
Disease control Not yet recruitingThis study is testing if taking a higher dose of the lung cancer drug furmonertinib every other day is more effective and safe for patients whose cancer has spread to the lining of the brain and spinal cord. It will enroll 42 adults with a specific genetic mutation (EGFR) whose c…
Matched conditions: FURMONERTINIB
Phase: NA • Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Brain vs. body: new trial tests stronger drug dose against Drug-Chemo combo for tough lung cancer
Disease control Not yet recruitingThis study aims to find the better first treatment for people with a specific type of lung cancer (EGFR-mutated NSCLC) that has spread to the brain. It will compare a higher dose of the targeted drug furmonertinib taken alone against a lower dose of the same drug combined with tw…
Matched conditions: FURMONERTINIB
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC